Hemosate Ultra Hs4125 1.11 g (Sodium Acetate SOLUTION) 1.11 G

HEMOSATE ULTRA HS4125 1.11 G is a sodium acetate solution used in haemodialysis. This product supports electrolyte balance during dialysis procedures. Ideal for medical professionals and dialysis centers.

Strength

1.11 G

Manufacturer / TM Owner

CHIEF MEDICAL SUPPLIES LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

HEMOSATE ULTRA HS4125 1.11 G is primarily used in haemodialysis to maintain electrolyte balance. Sodium acetate is a key component in dialysis solutions, helping to regulate sodium levels in the blood. This solution is designed for use in medical settings where precise electrolyte management is crucial.

Side Effects

When used as directed, HEMOSATE ULTRA HS4125 1.11 G helps maintain stable sodium levels during haemodialysis. It supports the overall effectiveness of the dialysis process by ensuring proper electrolyte balance. Users may notice improved comfort and efficiency during treatment.

Precautions & Warnings

HEMOSATE ULTRA HS4125 1.11 G should be handled with care, following standard medical protocols. Ensure proper storage and use in a controlled environment. Always consult healthcare professionals for specific guidelines and precautions related to haemodialysis solutions.

Avoid Interactions

Sodium acetate solutions like HEMOSATE ULTRA HS4125 1.11 G may interact with other medications or supplements. It is important to inform healthcare providers about all current treatments before using this product. Always follow medical advice regarding potential interactions.

Frequently Asked Questions

HEMOSATE ULTRA HS4125 1.11 G is used in haemodialysis to maintain electrolyte balance, specifically regulating sodium levels in the blood.

HEMOSATE ULTRA HS4125 1.11 G should be stored according to the manufacturer's instructions, typically in a cool, dry place away from direct sunlight.

Potential interactions with other medications should be discussed with a healthcare provider before using HEMOSATE ULTRA HS4125 1.11 G.

When used as directed, HEMOSATE ULTRA HS4125 1.11 G helps maintain stable sodium levels during haemodialysis, supporting the overall effectiveness of the dialysis process.

HEMOSATE ULTRA HS4125 1.11 G should be handled by medical professionals trained in haemodialysis procedures.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.